Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - SHORT-TERM DEBT
Short-term Debt FOLD - Amicus Therapeutics, Inc.
8.32 M
LAST VALUE
-25.05%
2 YEAR CAGR
0.00%
5 YEAR CAGR
39.47%
10 YEAR CAGR